ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Circulating microRNA 134 sheds light on the diagnosis of major depressive disorder

Han-ping, Zhang; Xiao-lei, Liu; Jian-jun, Chen; Ke, Cheng; Shun-Jie, Bai; Peng, Zheng; Chan-juan, Zhou; Wei, Wang; Hai-yang, Wang; Lian-mei, Zhong; Peng, Xie
Translational Psychiatry2020-12DOI: 10.1038/s41398-020-0773-2
5被引4阅读
引用收藏
分享

摘要

<jats:title>Abstract</jats:title><jats:p>Major depressive disorder (MDD) is a prevalent and debilitating psychiatric mood disorder that lacks objective laboratory-based tests to support its diagnosis. A class of microRNAs (miRNAs) has been found to be centrally involved in regulating many molecular processes fundamental to central nervous system function. Among these miRNAs, miRNA-134 (miR-134) has been reported to be related to neurogenesis and synaptic plasticity. In this study, the hypothesis that plasma miR-134 can be used to diagnose MDD was tested. Perturbation of peripheral and central miR-134 in a depressive-like rat model was also examined. By reverse-transcription quantitative PCR, miR-134 was comparatively measured in a small set of plasma samples from MDD and healthy control (HC) subjects. To determine its diagnostic efficacy, plasma miR-134 levels were assessed in 100 MDD, 50 bipolar disorder (BD), 50 schizophrenic (SCZ), and 100 HC subjects. A chronic unpredictable mild stress (CUMS) rat model was also developed to evaluate miR-134 expression in plasma, hippocampus (HIP), prefrontal cortex (PFC), and olfactory bulb. We found that plasma miR-134 was significantly downregulated in MDD subjects. Diagnostically, plasma miR-134 levels could effectively distinguish MDD from HC with 79% sensitivity and 84% specificity, while distinguishing MDD from HC, BD, and SCZ subjects with 79% sensitivity and 76.5% specificity. Congruent with these clinical findings, CUMS significantly reduced miR-134 levels in the rat plasma, HIP, and PFC. Although limited by the relatively small sample size, these results demonstrated that plasma miR-134 displays potential ability as a biomarker for MDD.</jats:p>

相关
加载中…
  • Deciphering the neural mechanisms of miR-134 in major depressive disorder with population-based and person-specific imaging transcriptomic techniques
    Lou, Jing; Liu, Kai; Wen, Junyan; He, Yini; Sun, Yuqing; Tian, Xiaohan; Hu, Ke; Deng, Yanjia*; Liu, Bing*; Wen, Ge*PSYCHIATRY RESEARCH, 2023, 329: 115551.
  • Effective biomarkers and therapeutic targets of nerve-immunity interaction in the treatment of depression: an integrated investigation of the miRNA-mRNA regulatory networks
    Wu, Zixuan; Cai, Zhixiang; Shi, Hongshuo; Huang, Xuyan; Cai, Minjie; Yuan, Kai; Huang, Peidong; Shi, Guoqi; Yan, Tao; Li, Zhichao*Aging-US, 2022, 14(8): 3569-3596.被引 6
  • Reduced cerebral cortex thickness is related to overexpression of exosomal miR-146a-5p in medication-free patients with major depressive disorder
    Deng, Yanjia; Gong, Ping; Han, Shuguang; Zhang, Jingyu; Zhang, Shuai; Zhang, Bin; Lin, Yong; Xu, Kai; Wen, Ge*; Liu, Kai*PSYCHOLOGICAL MEDICINE, 2023, 53(13): 6253-6260.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Translational Psychiatry
发表日期
2020-12
卷期
第 10 卷, 第 1 期
页码
95
DOI
10.1038/s41398-020-0773-2

作者

  • H

    Han-ping, Zhang (第一作者)

  • X

    Xiao-lei, Liu

查看全部 11 位作者收起作者
  • J

    Jian-jun, Chen

  • K

    Ke, Cheng

  • S

    Shun-Jie, Bai

  • P

    Peng, Zheng

  • C

    Chan-juan, Zhou

  • W

    Wei, Wang

  • H

    Hai-yang, Wang

  • L

    Lian-mei, Zhong

  • P

    Peng, Xie

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417